Skip to main content
Clinical Trials/ISRCTN90063632
ISRCTN90063632
Completed
Not Applicable

Research on the comprehensive therapy for impaired glucose tolerance (IGT) by traditional Chinese medicine

Ministry of Science and Technology of the People's Republic of China (China)0 sites2,000 target enrollmentStarted: July 10, 2008Last updated:

Overview

Phase
Not Applicable
Status
Completed
Sponsor
Ministry of Science and Technology of the People's Republic of China (China)
Enrollment
2,000

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1\. Both males and females
  • 2\. 25 \=\< age \<\=70
  • 3\. Intravenous plasma glucose: Fasting plasma glucose (FPG) \<7\.0 mmol/L and 2\-hour plasma glucose (2hPG) of oral glucose tolerance test (OGTT) \<11\.1 mmol/L, \>\=7\.8 mmol/L
  • 4\. Deficiency of both qi and yin syndromes accompanied by heat
  • 5\. Taking no medicine for treatment of IGT
  • 6\. 18\.5 kg/m2 \< body mass index (BMI) \<30 kg/m2
  • 7\. Voluntariness, and signed letter of consent
  • 8\. Those who do not take part in any other trails within 3 months

Exclusion Criteria

  • 1\. Acute cardiovascular disease and myocardial infarction within 6 months
  • 2\. Proliferative retinopathy that needs to be treated by laser
  • 3\. Not compliant
  • 4\. Mental disease
  • 5\. Pregnant or lactating women; women without contraception
  • 6\. Allergic to any traditional chinese medicine
  • 7\. Co\-morbid with other endocrine disease or serious protopathy
  • 8\. Systolic blood pressure (SBP) \>\= 160 mmHg, diastolic blood pressure (DBP) \>\= 100 mmHg and secondary hypertension
  • 9\. Cholesterol (CHO) \>\= 6\.22 mmol/L(240 mg/dl) or low density lipoprotein (LDL) \>\= 4\.14 mmol/L (160 mg/dl)
  • 10\. Patients who are treated by other hypoglycemic drug

Investigators

Sponsor
Ministry of Science and Technology of the People's Republic of China (China)

Similar Trials